Clinical Trials at NZOZ WCA
During the past decade, NZOZ WCA conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on
average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at NZOZ WCA
According to Clinical.Site data, the most researched conditions in "NZOZ WCA" are
"Alzheimer Disease" (3 trials), "Alzheimer's Disease" (3 trials) and "Alzheimers Disease" (2 trials). Many other conditions were trialed in "NZOZ WCA" in a lesser frequency.
Clinical Trials Intervention Types at NZOZ WCA
Most popular intervention types in "NZOZ WCA" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Gantenerumab" (4 trials), "Semorinemab" (2 trials), "[18F]GTP1" (2 trials) and "Crenezumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at NZOZ WCA
The vast majority of trials in "NZOZ WCA" are
8 trials for "All" genders.
Clinical Trials Status at NZOZ WCA
Currently, there are NaN active trials in "NZOZ WCA".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in NZOZ WCA,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in NZOZ WCA, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".